Drugs.com - Pharma Industry News

Study Finds Exenatide Not Beneficial for Parkinson Disease

FRIDAY, Feb. 7, 2025 -- The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, according to a study published online Feb. 4 in The Lancet. Nirosen Vijiaratnam, M.D., from the...

Feb 9, 2025 - 22:25
 0
Study Finds Exenatide Not Beneficial for Parkinson Disease
FRIDAY, Feb. 7, 2025 -- The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, according to a study published online Feb. 4 in The Lancet. Nirosen Vijiaratnam, M.D., from the...
Read More

Tags:

Previous Article

Tonsillectomy Effective for Nocturnal Enuresis in Children With Sleep Apnea

Next Article

Live Birth Rate Lower With Frozen Versus Fresh Embryo Transfer

Related Posts

Chronic Medical Conditions Take Toll on Employees

Chronic Medical Conditions Take Toll on Employees

Feb 14, 2025  0

Transcutaneous Electrical Stimulation Aids Gastroesophageal Reflux Disease

Transcutaneous Electrical Stimulation Aids Gastroesopha...

Feb 9, 2025  0

Risk for Postpartum CVD Readmissions Higher for Twin Pregnancies

Risk for Postpartum CVD Readmissions Higher for Twin Pr...

Feb 10, 2025  0